Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Earth Science Tech, Inc. (ETST) Pursues Growth Through Product Development, Joint Ventures and Acquisitions

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields as well as medical devices and research and development, is poised to gain its share of the ever-growing cannabis sector. An article discussing the company reads: “To enter this brave new world of cannabis liberalization, ETST is developing a portfolio of new products while aggressively pursuing growth through joint ventures and acquisitions. In this vein, newly created division Cannabis Therapeutic Inc. will develop proprietary cannabinoid-based nutraceuticals and pharmaceutical products based on an existing CBD patent. The company continues its activities in the hemp-derived cannabinoid (CBD), nutraceutical, pharmaceutical and medical device markets. In addition, it is pursuing a vigorous program of R&D and continued development of its marketing and distribution channels.”

To view the full article, visit http://ibn.fm/sa2oD

About Earth Science Tech, Inc.

Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality, high-grade full spectrum cannabinoid oil on the market. Thanks to its positive result studies on breast cancer and immune cells through the University of Central Oklahoma, studies through DV Biologics proving to lower cortisol and as a neuroprotectant, positive result case studies through key health organizations. ETST formulates, markets, and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD in the market.  For more information, visit the company’s website at www.EarthScienceTech.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Earth Science Tech, Inc. ETST, MissionIRNewsBreaks | Leave a comment

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Targeting Growing CBD Pet Market with New Product Line

  • Company’s new products are designed to address issues such as inflammation, joint pain, post-surgery pain and skin disorders in pets
  • CBD pet market is heating up, with a growing number of cannabis companies already manufacturing products for this niche
  • Pet owners spend more than $30 billion a year on supplements and other veterinary treatments, making CBD pet products a lucrative opportunity

The multiple uses of cannabidiol (CBD) for domesticated animals, especially for dogs and cats, are gaining considerable attention from both consumers and the cannabis industry as a whole, with a growing number of cannabis companies tapping into this lucrative market sector. Canadian-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) already has several CBD-based pet products in development, targeting indications such as inflammation, post-surgical pain and joint pain, as well as skin disorders.

Pivot recently announced that it was accelerating development of its CBD pet product line, which will be marketed under the name ‘Pivot Naturals For Pets’ (http://ibn.fm/mNAiy). This product line will include capsules and sachets to deliver bio-available CBD, using Pivot’s proprietary and patented Ready-To-Infuse-Cannabis powder. In addition, the company is using its Thrudermic Transdermal Nanotechnology to develop and commercialize a series of CBD pet creams for topical application.

“With Pivot’s line of pet products, the pain-relieving effects of CBD can be delivered orally, topically or as an additive sprinkled on pet food. Pivot’s technologies are versatile and allow us to develop and commercialize products for both the human and veterinary markets,” Dr. Joseph Borovsky, Pivot’s executive vice president, product development, stated in a news release. He added that the company’s patented technologies will allow it to continue its innovation process to bring dozens of value-added derivatives to market in Canada, the United States and the European Union.

The Canadian cannabis market is yet to reach its full potential, with an exponential increase expected this year once the country fully legalizes cannabis. Legalization, in combination with a growing demand for CBD products for pets in both Canada and the U.S., is expected to make this investment avenue a very lucrative opportunity. According to the American Pet Products Association, pet owners in the U.S. spent more than $30 billion on supplements and other veterinary treatments in 2016. The U.S. pet medicine market alone is estimated at roughly $10.2 billion.

With several studies indicating that CBD interacts in a similar way in canines and felines, making it a viable option to address a wide range of issues such as anxiety, allergies, lack of appetite, arthritis or skin problems (http://ibn.fm/jzzFP), Pivot can successfully leverage its experience and innovative manufacturing technologies to take a leading position in the CBD pet market.

The company is already well positioned to develop industry-leading, high-quality cannabinoid-based products for pharmaceutical and nutraceutical use, through proprietary drug delivery platforms via its own medical cannabis product division, Pivot Green Stream Health Solutions (“PGS”). Responsible for the research, development and commercialization of the company’s products, PGS has acquired global rights for several patented technologies, including BiPhasix™ transdermal drug delivery, Solmic oral solubilization, Thrudermic Transdermal Nanotechnology and Ready-to-Infuse-Cannabis powder-to-oil technology. These technologies are at the foundation of the company’s pipeline of pharmaceutical products, which target different ailments and conditions ranging from cancer supportive care to glaucoma, women’s sexual desire disorder, dermatological conditions, opioid withdrawal, pain and inflammation, and many others.

For more information, visit the company’s website at www.PivotPharma.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Reports Increase in Revenue, Debt Conversion in Q1 2018

Global life sciences company Pressure BioSciences (OTCQB: PBIO) recently announced financial results for the first quarter ended March 31, 2018. Among other highlights, the company reported first quarter revenue growth and debenture conversion. An article discussing the report further reads: “The first quarter of 2018 was the ninth consecutive quarter in which the company reported an increase in products and services revenue on a year-over-year basis and the second time during the past year in which the company reported total quarterly revenue of more than $600,000. Sales of the company’s instruments established a new quarterly record, and sales of the instruments’ consumable elements increased by 18 percent following on a 21 percent revenue increase for the final quarter of 2017. … In addition to the revenue achievements, the company reported that, operationally, it was advancing in its relationships with clients as a new cadre of sales directors began working in their assigned geographical areas.”

To view the full article, visit http://ibn.fm/dUDJ6

About Pressure BioSciences Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of the company’s pressure-based technologies in the following areas: (1) the use of its recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Hammer Fiber Optics Holdings Corp. (HMMR) Restructures Business to Better Serve the Market While Expanding Offerings

Hammer Fiber Optics Holdings Corp. (OTCQB: HMMR), a telecommunications company investing in the future of wireless technology, recently announced that its wholly owned subsidiary, Hammer Fiber Optic Investments Ltd., was changing its DBA name from Hammer Fiber to Hammer Communications. An article discussing the company reads: “In the restructure of Hammer Fiber Optic Investments, Hammer Fiber will remain as a business unit of Hammer Communications. It will offer and manage carrier and wholesale services across Hammer Communications’ network covering New York, New Jersey and Pennsylvania, as well as providing services to businesses within these states. The global fiber optics market is projected to grow at a CAGR of 9.4 percent, from $3.2 billion in 2017 to $5 billion in 2022 (http://ibn.fm/kjBS9).”

To view the full article, visit http://ibn.fm/EK8o3

About Hammer Fiber

Hammer Fiber Optic Holdings Corp. (OTCQB: HMMR) is a telecommunications company investing in the future of wireless technology whose holdings include Hammer Fiber Optic Investments, Ltd. D/B/A Hammer Communications, that offers internet, voice, video and data services in New Jersey, through both direct fiber as well as its wireless fiber platform, Hammer Wireless® AIR technology. The Hammer Wireless Air technology can support a variety of applications including mobile-to-mobile, wireless DOCSIS, IoT and Smart City support as well as pre-5G network applications. For more information, visit the company’s website at www.HammerComm.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Hammer Fiber Optics Holdings Corp. HMMR, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Set to Release 1Q18 Financial Results on May 30, 2018

Vertically integrated cannabis company Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) this morning announced plans to release its first quarter 2018 financial results after market close on Wednesday, May 30, 2018. Per the update, the company’s executive management team will discuss the results during a conference call on Thursday, May 31, 2018, at 11:00 am Eastern Time. Those interested in participating in the call may do so by dialing 1-800-319-4610 or 604-638-5340. An audio replay will be made available shortly after the conclusion of the call for a period of two weeks. To access this replay, interested parties should dial 1-855-669-9658 or 604-674-8052 and enter access code 2365.

To view the full press release, visit http://ibn.fm/TkGDh

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – where it is committed to delivering safe, high-quality products and services at scale. The company’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built current good manufacturing practices greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries. For more information, visit the company’s website at www.sunniva.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Sunniva Inc. SNNVF | Leave a comment

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Products Envision World of Reduced Traffic Accidents

  • Detection systems provide drivers with safety features that cut through all weather and lighting conditions
  • Foresight’s trademark QuadSight system utilizes stereo vision technology, coupled with infrared and visible light cameras, to detect objects under all weather and lighting conditions
  • Additional products are Eyes-On, an advanced ADAS system, and Eye-Net, a cellular-based accident prevention solution
  • ADAS market forecast: $79 billion by 2020 amid automaker demand for safety systems

“Driverless” autonomous and semi-autonomous vehicles are becoming more commonplace despite societal concerns about the risks of not having someone in control as a car speeds along. Forward-facing cameras in many of the latest models of legacy automotive brands allow vehicles to “see” where lane markings are and assess the behavior of other vehicles on the road, giving consumers a growing degree of confidence in their safety, and some companies are taking the capabilities of Advanced Driver Assistance Systems (ADAS) technologies to next-level applications, such as the recently debuted QuadSight system that Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) has developed to detect roadway objects under all weather and lighting conditions.

Basic ADAS systems rely on mono visible light cameras that detect movement, but a variety of companies are introducing more complex systems that may incorporate stereo vision, radar, lidar and infrared sensors. QuadSight is driven by advanced and proven image processing algorithms, utilizing a four-camera set up that includes two sets of stereoscopic infrared and visible light cameras, enabling highly accurate and reliable obstacle detection, even when weather conditions make visibility poor for drivers.

“Vision is the foundation of passenger safety, and vision perfection under all weather and lighting conditions is clearly the breakthrough that vehicle makers need to build consumer confidence in order to accelerate autonomous vehicle adoption,” CEO Haim Siboni stated in a January news release announcing the company’s entry at the tech industry’s annual CES show in Las Vegas (http://ibn.fm/0wAeD).

Foresight Autonomous Holdings is building on the demo version it produced, creating a prototype for pilot projects that will take place on public roads, and the company expects to see the system finished and commercialized during the second half of next year. An autonomous vehicle built on sound quality principles has the potential to improve traffic safety, virtually eliminating the likelihood of texting-while-driving fatalities, for example, or crashes that occur while someone is reaching for an item.

Electronic Design magazine noted that Foresight’s QuadSight system can detect details better than the human eye by using a passive camera system that processes visual input rather than relying on signal response from lidar and radar systems (http://ibn.fm/psYXC). The company has developed three main products; in addition to QuadSight’s visual perceptiveness, Foresight developed the Eyes-On system, a unique stereo vision Advanced Driver Assistance System (ADAS) using advanced algorithms for accurate depth analysis and obstacle detection, and the Eye-Net system, a cellular-based accident prevention solution designed to provide real-time pre-collision alerts to pedestrians and vehicles that are not in direct line-of-sight and not covered by other alerting systems.

The Eye-Net solution is deployed on smartphones and cloud-based servers which rely on existing cellular networks, eliminating the need for designated hardware. It was developed for use in both urban environments and high-speed highway scenarios. In early May, Foresight announced a merger agreement that will spin Eye-Net off into a new wholly-owned subsidiary and then transfer 100 percent of its subsidiary’s share capital to Tamda, Ltd. (TASE: TMDA) in exchange for a nearly 75 percent stake in Tamda’s share capital.

The company has further demonstrated its commitment to traffic safety by investing in RailVision — a company that develops advanced vision systems to manage safety and maintenance issues on railways. RailVision has completed 13 tests of its systems in Israel, where Foresight is based, and throughout Europe.

Infoholic Research has forecast that the autonomous vehicle market will reach $126.8 billion worldwide by 2027 (http://ibn.fm/lvtPa), and Mordor Intelligence foresees a $79 billion market for ADAS alone by 2020 with a CAGR of 28 percent as a result of current demand for new driver assistance systems (http://ibn.fm/8rOdb).

For more information, visit the company’s website at www.ForesightAuto.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Foresight Autonomous Holdings Ltd. FRSX | Leave a comment

MissionIRNewsBreaks – SeeThruEquity Issues Update on Net Element, Inc. (NASDAQ: NETE)

SeeThruEquity, an independent equity research and corporate access firm focused on smallcap and microcap public companies, this morning issued a company update on global technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE). Net Element recently reported first quarter 2018 results, including revenues of $16 million, representing an increase of approximately 18% versus $14 million for the same period of the previous year. Strong execution in the company’s North America Transactions Solutions business segment was credited as the driving force behind the revenue growth for the quarter. The report also highlighted the company’s growth in transaction volume, particularly in North America, and narrowing losses for the quarter. SeeThruEquity plans to reassess its price target, which remains unchanged, following an update by the company regarding its development and its prospects for blockchain in the coming year.

To view the full press release, visit http://ibn.fm/HWapZ

About Net Element

Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S., it aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, the company’s cloud based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500™. In 2017, Net Element was recognized by South Florida Business Journal’s as one of 2016’s fastest growing technology companies. Further information is available at www.NetElement.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Net Element Inc. NETE | Leave a comment

MissionIRNewsBreaks – Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) to Participate at WBF: Security Tokens & ICOs Conference in NYC

Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) this morning announced that it will be partnering with Keynote to bring the World Blockchain Forum to the first WBF: Security Tokens & ICOs conference taking place on June 12-13, 2018 in New York City. More than 1,000 major stakeholders in the blockchain and cryptocurrency sector are anticipated to attend the conference. Peter Smyrniotis, a member of the Board of Directors of Victory Square and CEO of Blockchain Assembly Inc., will present on June 12, 2018, at 10:50 am ET. Together, Victory Square and Blockchain Assembly will be hosting a $100,000 Investment Prize pool for the top three blockchain companies during the WBF’s Pitch Your ICO session. “These conferences are strategically essential for us and New York will allow us to connect with the some of the most respected blockchain thought-leaders, institutional investors, regulators, leading companies and projects in the world, while at the same time showing off our own exceptional entrepreneurs and portfolio companies,” Victory Square CEO Shafin Diamond Tejani stated in the news release.

To view the full press release, visit http://ibn.fm/i1vlv

About Victory Square Technologies Inc.

Victory Square Technologies is a blockchain-focused venture builder that funds and empowers entrepreneurs to implement innovative blockchain solutions. Victory Square portfolio companies are disrupting every sector of the global economy including Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. Victory Square has a proven process for identifying game-changing entrepreneurs and providing them with the partners, mentorship and support necessary to accelerate their growth and help them scale globally. For more information, please visit www.VictorySquare.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Victory Square Technologies Inc. VSQTF | Leave a comment

Earth Science Tech, Inc.’s (ETST) Finalized Audits Provide a Boost to Investor Confidence

  • Company recently announced that its 2015 and 2016 YE audits have been finalized, its Form 10 has been submitted and it has commenced its 2017 fiscal year audit
  • Strategically working to improve treatments for different diseases on a global scale
  • Addressing the national health crisis of opioid addiction

Earth Science Tech, Inc. (OTC: ETST), an innovative biotech company focused on developing medical devices for the pharmaceutical and nutraceutical fields and marketing high-grade hemp cannabidiol (CBD), recently announced that its 2015 and 2016 audit process has been finalized and Form 10 has been submitted. ETST has now begun the 2017 fiscal year audit, which is required to uplist to the OTCQB Venture Market, along with the approved Form 10.

In a news release (http://ibn.fm/Xa90R), Dr. Michel Aube, CEO and chief science officer of ETST, stated, “Transparency is a key tool that we needed to accelerate the growth of our business. Since all of our amazing projects are ongoing with our partners, investor confidence will grow, and we will be able to complete our first big round of financing. We are in touch with institutional and private investors that were waiting for ETST to become a fully reporting company before investing the necessary amount to commercialize our projects. We can now resume our discussions with them.” Becoming a fully reporting OTCQB company is expected to open many opportunities while simultaneously boosting investor confidence. An Audio Press Release (APR) of this announcement is available at http://ibn.fm/itTdR.

Earth Science Tech is a biotechnology company based in Florida that’s focused on the science, research and study of high-grade hemp cannabinoid (CBD) oil as a nutraceutical and dietary supplement. ETST is working to improve treatments for different diseases on a global scale through its subsidiaries: Earth Science Pharmaceutical, Cannabis Therpeutics Inc., Kannabidioid Inc., and Canna Inno Laboratories Inc. Its Earth Science Pharmaceutical subsidiary is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases (STIs). Cannabis Therapeutics is also a subsidiary of ETST, and it was formed as an emerging biotech company poised to become a world leader in CBD research and development. In the recreational space, ETST owns Kannabidioid, a subsidiary focused on manufacturing and distributing vapes/e-liquids and gummy edibles. The acquisition of Canna Inno Laboratories in Quebec granted ETST access to the growing Canadian market and government funding. It has already received a supporting grant for innovation in the pharmaceutical industry. The company has plans to apply for additional funding under Canada’s Scientific Research and Experimental Development Tax Credit program.

ETST has also taken on a new fight – opioid addiction. Human clinical trials are scheduled to begin in 2019. With the opioid epidemic projected to claim nearly 500,000 American lives by 2027 (http://ibn.fm/x4tI2), the company seeks to improve the treatment of those fighting dependency. The goal of the study is to reduce the cravings of opioid addicts and reduce the danger of side effects while making the drug more effective. This is just one of many ways that ETST is committed to improving treatments for different diseases worldwide.

Additional transparency, a strengthening of current subsidiaries through new studies and markets, the rise of the cannabis industry, access to government grants in Canada and a commitment to finding solutions to the national epidemic of opioid addiction are all small key parts in a much larger strategic plan for accelerated growth.

For more information, visit the company’s website at www.EarthScienceTech.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Earth Science Tech, Inc. ETST | Leave a comment

MissionIRNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Subsidiary Launches Intelligent Payment Solution for the Events Industry

Global technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) this morning announced that its subsidiary, Unified Payments, has launched an intelligent payment solution for the meetings and events industry – a market that accounts for over $330 billion in annual direct spending, according to a recent report from The Events Industry Council. Per the update, the integrated payment solution enhances existing payment acceptance services with intelligent integration for point-of-sale systems, self-order kiosks, chargeback protection and multi-channel payment acceptance. “We are excited to provide the event management industry with fully integrated, feature rich payment acceptance solutions,” Vlad Sadovskiy, president of integrated payments for Net Element, stated in the news release. “Our capabilities have the potential to dramatically change the way event transactions are processed today.”

To view the full press release, visit http://ibn.fm/Izyx2

About Net Element

Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S., it aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, the company’s cloud based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500™. In 2017, Net Element was recognized by South Florida Business Journal’s as one of 2016’s fastest growing technology companies. Further information is available at www.NetElement.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Net Element Inc. NETE | Leave a comment